Please provide your email address to receive an email when new articles are posted on . Disease progression occurred in more patients receiving placebo vs. an oral lysophosphatidic acid receptor 1 ...

TTP following R-CHOP is a strong prognostic factor for survival in R/R DLBCL, with shorter TTP linked to poorer outcomes. Real-world data shows patients with TTPs under 12 months have lower survival ...

Cabometyx plus Tecentriq led to improved progression-free survival compared with novel hormonal therapy in patients with metastatic castration-resistant prostate cancer. The combination of Cabometyx ...

Pregnancy post-glioma diagnosis is associated with worse progression-free survival, but no deterioration occurs during pregnancy itself. Patients who had children after glioma diagnosis showed a 2.45 ...

ROOT, Switzerland--(BUSINESS WIRE)-- Novocure (NASDAQ: NVCR) today announced the phase 3 METIS clinical trial met its primary endpoint, demonstrating a statistically significant improvement in time to ...

Centrilobular emphysema (CLE) is independently associated with the progression of coronary artery calcification (CAC) over time.